Actuate Therapeutics(us:ACTU)

6.70

-1.03%

Updated on 2025-04-02

Open:7.30
Close:6.70
High:7.30
Low:6.70
Prev Close:6.77
Volume:8546.00
Turnover:59508.36
Turnover Ratio:0.04%
Shares:19.53M
MarketCap:130.86M

About Actuate Therapeutics

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Company Name: Actuate Therapeutics
Address: 1751 River Run,Suite 400
Employees:
Fiscar Year:
IPO Date:
Website:
CIK: 1652935

View all SEC Filings

About

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
Address:1751 River Run,Suite 400
Website:

Market Movers